Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invion.
RELATED STOCKHEAD STORIES
News
Weekly ASX small cap wrap: Who’s cruising ahead this week?
News
10 at 10: These ASX stocks have risen to the skies this morning
News
May Winners Column: Uranium, biotechs and real estate takeover targets put in the hard yards on the ASX
Health & Biotech
Invion led a group of ASX cancer stocks up after promising news
News
ASX Small Cap Lunch Wrap: Biden’s less-generous infrastructure bill is somehow good news for share markets
News
10 at 10: These ASX stocks have made the biggest launch this morning
Health & Biotech
Mesoblast burnt $108m in FY20 waiting on key FDA ruling
Health & Biotech
Health: Amplia really gives a FAK about cancer as phase 1 trial still on track
Health & Biotech
Selvax cures cancer in dogs, says it’s eyeing an IPO
Health & Biotech
Invion says lasers can trigger anti-cancer immune response in mice
Health & Biotech
Dr Boreham’s Crucible: This is the only ASX-listed biotech in the photodynamic therapy game
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Health: Invion may have found its break in Chinese dermatology
Health & Biotech
Check-up: Lasers and fatty livers won in biotech this month
News
Spies and corporate takeovers: what’s next for the China-Australia story?
Health & Biotech
Health: Fricken lasers shrink ovarian cancer (also look good on sharks)
Health & Biotech
